Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy
Clinical trial NCT02732015 · TERMINATED
Trial details
- NCT number
- NCT02732015
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-12
- Primary completion
- 2020-07-10
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.